Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
2(29%)
Results Posted
50%(1 trials)
Terminated
3(43%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_3
1
14%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Terminated(3)

Detailed Status

Terminated3
Completed2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
40.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

recruiting114%
completed229%
terminated343%
active_not_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7